| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,156 |
6,359 |
$1.34M |
| 0223U |
|
2,697 |
2,481 |
$897K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,912 |
2,368 |
$777K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
2,792 |
1,884 |
$629K |
| A0425 |
Ground mileage, per statute mile |
3,159 |
2,069 |
$514K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
572 |
557 |
$232K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,778 |
5,358 |
$198K |
| 80050 |
General health panel |
4,710 |
4,248 |
$193K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,699 |
1,551 |
$140K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,706 |
1,922 |
$136K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
140 |
73 |
$77K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,242 |
1,113 |
$43K |
| 71046 |
Radiologic examination, chest; 2 views |
412 |
333 |
$35K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
487 |
139 |
$35K |
| 70450 |
Computed tomography, head or brain; without contrast material |
82 |
79 |
$31K |
| G0378 |
Hospital observation service, per hour |
176 |
100 |
$30K |
| 80053 |
Comprehensive metabolic panel |
3,057 |
2,484 |
$29K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,479 |
3,154 |
$29K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
242 |
234 |
$28K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
101 |
53 |
$26K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
26 |
25 |
$24K |
| G0379 |
Direct admission of patient for hospital observation care |
140 |
84 |
$23K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
179 |
114 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
246 |
215 |
$17K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
2,031 |
612 |
$17K |
| 80061 |
Lipid panel |
1,401 |
1,326 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
454 |
423 |
$16K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
455 |
424 |
$16K |
| 99221 |
|
715 |
563 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
174 |
57 |
$12K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
145 |
75 |
$12K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
729 |
557 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
497 |
454 |
$8K |
| 83721 |
|
1,440 |
1,275 |
$8K |
| 83655 |
|
568 |
536 |
$7K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
50 |
49 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
955 |
855 |
$7K |
| 83880 |
|
254 |
194 |
$7K |
| 99218 |
|
293 |
243 |
$6K |
| 80047 |
|
752 |
447 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
113 |
97 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
210 |
119 |
$6K |
| 0001A |
|
330 |
158 |
$6K |
| 0002A |
|
280 |
146 |
$6K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
84 |
82 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
496 |
429 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
141 |
87 |
$5K |
| J3490 |
Unclassified drugs |
411 |
344 |
$5K |
| 83735 |
|
1,017 |
843 |
$5K |
| 99224 |
|
503 |
239 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
794 |
410 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
2,393 |
1,591 |
$4K |
| 84484 |
|
370 |
248 |
$3K |
| 0003A |
|
70 |
53 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
51 |
40 |
$2K |
| 82553 |
|
388 |
252 |
$2K |
| 94761 |
|
730 |
129 |
$2K |
| 82150 |
|
334 |
300 |
$2K |
| 84481 |
|
129 |
127 |
$1K |
| 82550 |
|
359 |
240 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
60 |
57 |
$1K |
| 84439 |
|
129 |
127 |
$1K |
| 81001 |
|
822 |
598 |
$950.76 |
| 80305 |
|
96 |
93 |
$945.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17 |
12 |
$657.83 |
| 86701 |
|
58 |
57 |
$506.73 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
456 |
356 |
$498.38 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
36 |
12 |
$496.73 |
| 85651 |
|
116 |
110 |
$444.60 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
41 |
26 |
$364.55 |
| 80335 |
|
14 |
14 |
$266.00 |
| 80369 |
|
14 |
14 |
$260.54 |
| 80372 |
|
14 |
14 |
$252.56 |
| 80373 |
|
14 |
14 |
$252.56 |
| 80332 |
|
14 |
14 |
$245.07 |
| 80366 |
|
14 |
14 |
$245.07 |
| 80323 |
|
14 |
14 |
$245.07 |
| 80338 |
|
14 |
14 |
$245.07 |
| 80368 |
|
14 |
14 |
$245.07 |
| 80357 |
|
14 |
14 |
$245.07 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
28 |
14 |
$219.83 |
| 80320 |
|
14 |
14 |
$178.22 |
| 80355 |
|
14 |
14 |
$175.14 |
| 80321 |
|
14 |
14 |
$159.74 |
| 83992 |
|
14 |
14 |
$140.00 |
| 80346 |
|
14 |
14 |
$129.50 |
| 91300 |
|
547 |
398 |
$124.16 |
| 80354 |
|
14 |
14 |
$119.00 |
| 80356 |
|
14 |
14 |
$119.00 |
| 80348 |
|
14 |
14 |
$119.00 |
| 80365 |
|
14 |
14 |
$119.00 |
| 80362 |
|
14 |
14 |
$119.00 |
| 80361 |
|
14 |
14 |
$119.00 |
| 80360 |
|
14 |
14 |
$115.50 |
| 80350 |
|
14 |
14 |
$115.50 |
| 80371 |
|
14 |
14 |
$115.50 |
| 80349 |
|
14 |
14 |
$115.50 |
| 80358 |
|
14 |
14 |
$113.82 |
| 80359 |
|
14 |
14 |
$108.50 |
| 80324 |
|
14 |
14 |
$108.36 |
| 80353 |
|
14 |
14 |
$105.56 |
| 82948 |
|
40 |
12 |
$97.28 |
| 80345 |
|
14 |
14 |
$79.87 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
12 |
$65.48 |
| 82044 |
|
15 |
14 |
$47.48 |
| 81003 |
|
22 |
21 |
$2.24 |
| T1015 |
Clinic visit/encounter, all-inclusive |
857 |
662 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
81 |
76 |
$0.00 |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
16 |
14 |
$0.00 |
| 81025 |
|
12 |
12 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14 |
14 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
259 |
216 |
$0.00 |
| 00000 |
|
704 |
481 |
$0.00 |
| 3008F |
|
30 |
23 |
$0.00 |
| A0999 |
Unlisted ambulance service |
40 |
25 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
37 |
35 |
$0.00 |
| A0398 |
Als routine disposable supplies |
40 |
25 |
$0.00 |